5 Best Healthcare Stocks to Buy and Hold for 3 Years

2. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders: 110

Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare stocks.

TheFly reported on April 13 that Mizuho reduced its price target on BSX to $90 from $115 while maintaining an Outperform rating. The adjustment was part of a broader update across the firm’s medical devices and diagnostics coverage ahead of upcoming first-quarter earnings. The revisions reflect updated estimates and outlook changes applied across multiple companies within the same sector review.

According to a regulatory filing, on March 30, Boston Scientific Corporation (NYSE:BSX) and Penumbra, Inc. each received a “Second Request” from the U.S. Federal Trade Commission as part of its antitrust review of their proposed merger. The request requires both companies to provide additional information, extending the Hart-Scott-Rodino review timeline until 30 days after full compliance, unless modified or concluded earlier by the agency.

The filing follows earlier submissions made by both firms in mid-February under standard regulatory procedures. Both companies stated they intend to respond promptly and continue cooperating with the FTC throughout the review process. The extended review period indicates ongoing regulatory scrutiny before any final approval decision is reached. The process is part of the FTC’s standard evaluation of large transactions to assess potential competitive impacts within the healthcare and medical technology sector.

Boston Scientific Corporation (NYSE:BSX) is a global medical device company that develops and manufactures minimally invasive medical technologies. It specializes in interventional cardiology, rhythm management, endoscopy, and urology solutions designed to improve patient care and treatment outcomes.